About Steven Pentelnik
Form D filings for Alphyn Biologics from 2020 to 2024 list Steven Pentelnik as executive officer.
Steven Pentelnik first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Steven Pentelnik in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Steven Pentelnik works with at each company, as listed on that company's latest Form D.
Alphyn Biologics, Inc. · Form D, May 20, 2024
JK
Jeffrey Kossak
Director
GP
Gary Pekoe
Executive officer and director
AM
Adel Mikhail
Director
RG
Roger Griggs
Director
NK
Neal Koller
Chief Executive Officer and director